DEM Biopharma, Inc.
www.dembiopharma.comDEM Bio is pioneering the next generation of immunotherapeutics that unleash macrophages and immune phagocytes to eliminate tumors by targeting ‘Don’t eat me’ (DEM) and ‘Eat me’ (EM) signals on cancer cells and macrophages. Founded by Longwood Fund and is supported by a syndicate of biotech investors and headquartered in Boston, MA.
Read more
DEM Bio is pioneering the next generation of immunotherapeutics that unleash macrophages and immune phagocytes to eliminate tumors by targeting ‘Don’t eat me’ (DEM) and ‘Eat me’ (EM) signals on cancer cells and macrophages. Founded by Longwood Fund and is supported by a syndicate of biotech investors and headquartered in Boston, MA.
Read more
Country
State
Massachusetts
City (Headquarters)
Newton
Industry
Employees
11-50
Founded
2022
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Scientific Officer
Email ****** @****.comPhone (***) ****-****Chief Financial Officer / Chief Operating Officer
Email ****** @****.comPhone (***) ****-****Co - Founder , Scientific Advisory Board Co - Chair
Email ****** @****.comPhone (***) ****-****Chief Executive Officer
Email ****** @****.comPhone (***) ****-****
Technologies
(1)
Reach decision makers at DEM Biopharma, Inc.
Free credits every month!
DEM Biopharma, Inc. FAQ
Newton, United States
Biotechnology Research
